Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by NaMi Lee
A Phase I/Ii Study of Poziotinib Combined With Paclitaxel and Trastuzumab in Patients With HER2-positive Advanced Gastric Cancer
Gastric Cancer
Cancer Research
Medicine
Oncology
Gastroenterology
Related publications
Phase I/Ii Study of S-1 Combined With Paclitaxel in Patients With Unresectable and/or Recurrent Advanced Gastric Cancer
British Journal of Cancer
Cancer Research
Oncology
Multicenter Phase II Study of Trastuzumab Plus S-1 Alone in Elderly Patients With HER2-positive Advanced Gastric Cancer (JACCRO GC-06)
Gastric Cancer
Cancer Research
Medicine
Oncology
Gastroenterology
O1-20-2a Randomized Phase II Study to Assess Trastuzumab Beyond Progression in HER2-positive Advanced Gastric Cancer: WJOG7112G
Annals of Oncology
Medicine
Oncology
Hematology
A Phase I Study of Napabucasin Plus Paclitaxel for Japanese Patients With Advanced/Recurrent Gastric Cancer
In Vivo
Biochemistry
Medicine
Genetics
Pharmacology
Molecular Biology
A Randomized, Controlled Phase II Trial of Neoadjuvant Ado-Trastuzumab Emtansine, Lapatinib, and Nab-Paclitaxel Versus Trastuzumab, Pertuzumab, and Paclitaxel in HER2-positive Breast Cancer (TEAL Study)
Breast Cancer Research
Cancer Research
Oncology
Clinical Significance of Intratumoral HER2 Heterogeneity on Trastuzumab Efficacy Using Endoscopic Biopsy Specimens in Patients With Advanced HER2 Positive Gastric Cancer
Gastric Cancer
Cancer Research
Medicine
Oncology
Gastroenterology
Docetaxel Versus Paclitaxel Combined With 5-Fu and Leucovorin in Advanced Gastric Cancer: Combined Analysis of Two Phase II Trials
Cancer Research and Treatment
Cancer Research
Oncology
Docetaxel and Cisplatin in Patients With Advanced Gastric Cancer: Results of Japanese Phase I/Ii Study
Gastric Cancer
Cancer Research
Medicine
Oncology
Gastroenterology
A Phase I Trial of Combination Trastuzumab, Lapatinib, and Bevacizumab in Patients With Advanced Cancer
Investigational New Drugs
Oncology
Pharmacology
